Literature DB >> 3782746

Arginine-vasopressin in essential hypernatremia.

M Fernandez Castaner, J M Vendrell Sala, W Ricart, J M Valentines, J Gaya, J Soler Ramon.   

Abstract

Dynamics of AVP secretion in a 14-year-old girl with essential hypernatremia, psychomotor retardation and optic nerve coloboma, are reported. Basal levels of AVP were similar to those of a control population, but disproportionately low in relation with natremies. Hypertonic saline and hydric restriction did not alter the AVP basal values, which were, instead, stimulated with orthostatism. AVP decreased during a water surcharge, but delayed elimination of water was observed. The existence of a moderate volume deficit, not corrigible with a chronic surcharge of water, together with the reversed diurnal pattern of water excretion and the AVP data, suggest--as a physiopathological basis of the syndrome--a severe anomaly of the osmoreceptors, with alteration of thirst and of the osmodependent AVP responses, so that the AVP secretion was regulated exclusively through volumetric mechanisms.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3782746     DOI: 10.1007/bf03346937

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  15 in total

1.  Symptomatic normovolemic essential hypernatremia. A clinical and physiologic study.

Authors:  F P Alford; B A Scoggins
Journal:  Am J Med       Date:  1973-03       Impact factor: 4.965

2.  "Essential" hypernatremia due to ineffective osmotic and intact volume regulation of vasopressin secretion.

Authors:  F R DeRubertis; M F Michelis; N Beck; J B Field; B B Davis
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

3.  Hypernatraemia, diabetes mellitus, hyperprolactinaemia, retarded growth and delayed puberty in a 14 year old girl. Effect of bromocriptine treatment.

Authors:  N C Christensen; C Hagen; M D Nielsen; S Petersen
Journal:  Acta Endocrinol (Copenh)       Date:  1981-01

4.  Volume receptor control of ADH release in essential hypernatremia.

Authors:  S J Rosansky; B D Nidus
Journal:  N Y State J Med       Date:  1981-03

5.  Recommended methods for measurement of red-cell and plasma volume: International Committee for Standardization in Haematology.

Authors: 
Journal:  J Nucl Med       Date:  1980-08       Impact factor: 10.057

6.  Recurrent hypernatremia; a proposed mechanism in a patient with absence of thirst and abnormal excretion of water.

Authors:  S B Conley; J T Brocklebank; I T Taylor; A M Robson
Journal:  J Pediatr       Date:  1976-12       Impact factor: 4.406

7.  Hypernatremia induces hyperlipemia and a fatty liver.

Authors:  A Hayek; P D Bryant; W F Woodside
Journal:  Metabolism       Date:  1983-01       Impact factor: 8.694

8.  Hypodipsia-hypernatremia syndrome.

Authors:  U Schaad; F Vassella; K Zuppinger; O Oetliker
Journal:  Helv Paediatr Acta       Date:  1979-02

9.  Essential hypernatraemia, antidiuretic hormone and neurophysin secretion: response to chlorpropamide.

Authors:  T W AvRuskin; S C Tang; C Juan
Journal:  Acta Endocrinol (Copenh)       Date:  1981-02

10.  Hypothalamic adipsia without demonstrable structural lesion.

Authors:  A Hayek; G T Peake
Journal:  Pediatrics       Date:  1982-08       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.